Challenges of Implementing Alternative Delivery Models for Genetic Counseling in Prostate Cancer

Video

Alanna K. Rahm, PhD, MS, discusses the challenges of implementing alternative delivery models for genetic counseling in prostate cancer.

Alanna K. Rahm, PhD, MS, an assistant professor at Geisinger Genomic Medicine Institute, discusses the challenges of implementing alternative delivery models for genetic counseling in prostate cancer.

The optimal genetic counseling approach may vary for men with prostate cancer, explains Rahm. For some, undergoing testing with a genetic counselor may be preferred while others may elect to have their oncologist or urologist perform the genetic test and follow-up with a genetic counselor later.

However, some institutions may not have the ability to offer in-person counseling, says Rahm. Instead, a telemedicine may be implemented if the healthcare system doesn’t have genetic counselors and assistants on site.

Harmonizing the outcomes for all those involved with genetic testing is an important step in understanding which delivery model works best in which clinical scenario, concludes Rahm.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD